Revenue (Quarterly) Chart

Historical Revenue (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2026 326.06M
June 30, 2026 290.52M
March 31, 2026 216.30M
December 31, 2025 193.62M
September 30, 2025 155.11M
June 30, 2025 167.87M
March 31, 2025 151.71M
December 31, 2024 163.64M
September 30, 2024 172.00M
June 30, 2024 162.75M
March 31, 2024 158.80M
December 31, 2023 171.67M
September 30, 2023 134.15M
June 30, 2023 176.86M
March 31, 2023 143.14M
December 31, 2022 140.48M
September 30, 2022 169.92M
June 30, 2022 227.71M
March 31, 2022 227.07M
December 31, 2021 196.29M
September 30, 2021 245.54M
June 30, 2021 272.54M
March 31, 2021 172.49M
December 31, 2020 130.75M
September 30, 2020 126.63M
Date Value
June 30, 2020 136.85M
March 31, 2020 100.63M
December 31, 2019 102.29M
September 30, 2019 99.73M
June 30, 2019 104.17M
March 31, 2019 92.43M
December 31, 2018 105.56M
September 30, 2018 135.74M
June 30, 2018 191.85M
March 31, 2018 190.42M
December 31, 2017 180.42M
September 30, 2017 188.54M
June 30, 2017 190.03M
March 31, 2017 118.06M
December 31, 2016 99.65M
September 30, 2016 105.50M
June 30, 2016 122.45M
March 31, 2016 87.07M
December 31, 2015 84.25M
September 30, 2015 80.35M
June 30, 2015 115.79M
March 31, 2015 105.20M
December 31, 2014 111.23M
September 30, 2014 135.22M
June 30, 2014 159.63M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
ASML Holding NV 13.42B
Applied Materials, Inc. 9.115B
Lam Research Corp. 8.219B
Nova Ltd. 254.96M
Axcelis Technologies, Inc. 215.18M